The Liver Meeting 2023-Liver Fibrosis SIG - AI for the Dxt & TxT of Liver Fibrosis

Liver Fibrosis SIG - AI for the Dxt & TxT of Liver Fibrosis - 3119

Video Transcription

Video Summary

Speakers in the video discussed the various applications of artificial intelligence (AI) in diagnosing and treating liver fibrosis. They emphasized the use of AI in histological assessment for more accurate and consistent evaluations, as well as in diagnosing diseases like NASH and HCC and selecting treatments based on genetic factors. AI is also used to automate the quantification of liver fat and stiffness through imaging methods like MRI. The speakers highlighted the importance of inclusive data and addressing biases when developing AI models for different populations. Furthermore, the speakers mentioned the integration of AI into experimental workflows to accelerate biomedical research, with a focus on enhancing medicine's understanding and developing effective therapies. The use of spatial transcriptomics combined with AI analysis was also discussed for studying cellular interactions within liver tissue. Overall, the conversation underscored how AI is transforming biomedical research, particularly in liver disease therapy, with an emphasis on the importance of diverse datasets and the integration of AI tools into clinical decision-making processes.

Keywords

artificial intelligence

diagnosing

treating

liver fibrosis

histological assessment

NASH

HCC

genetic factors

liver fat

stiffness

MRI imaging

biomedical research

spatial transcriptomics